The company
Faeth Therapeutics, Inc.
FTH · Nasdaq
FTH stood above a rising 150-day average in 39 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 28.2% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $5.1M
- Insider sales, 12 months
- $4.0M
- Officials’ trades on record
- 0
- Institutions holding
- 45 (+16)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 39 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Brian C. StephensonChief Financial Officer | bought | 4,400at $23.40 | 1 Jul 2026filed 1 Jul 2026 |
| Brian C. StephensonChief Financial Officer | bought | 600at $24.22 | 1 Jul 2026filed 1 Jul 2026 |
| Brian C. StephensonChief Financial Officer | bought | 1,910at $22.95 | 30 Jun 2026filed 1 Jul 2026 |
| Brian C. StephensonChief Financial Officer | bought | 1,638at $23.88 | 30 Jun 2026filed 1 Jul 2026 |
| Brian C. StephensonChief Financial Officer | bought | 4,255at $24.98 | 30 Jun 2026filed 1 Jul 2026 |
| Brian C. StephensonChief Financial Officer | bought | 831at $23.34 | 29 Jun 2026filed 1 Jul 2026 |
| Brian C. StephensonChief Financial Officer | bought | 580at $23.61 | 26 Jun 2026filed 26 Jun 2026 |
| Brian C. StephensonChief Financial Officer | bought | 4,212at $24.90 | 26 Jun 2026filed 26 Jun 2026 |
| Brian C. StephensonChief Financial Officer | bought | 1,358at $25.55 | 26 Jun 2026filed 26 Jun 2026 |
| Brian C. StephensonChief Financial Officer | bought | 100at $26.39 | 26 Jun 2026filed 26 Jun 2026 |
| Brian C. StephensonChief Financial Officer | bought | 2,891at $25.22 | 24 Jun 2026filed 26 Jun 2026 |
| Brian C. StephensonChief Financial Officer | bought | 3,000at $25.98 | 24 Jun 2026filed 26 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| MONTANOVA CAPITAL, LLCadded · filed 14 Aug 2026 | 2,020,103$50.5M | +1,985,554+5747.1% |
| Avoro Capital Advisors LLCnew · filed 14 Aug 2026 | 1,444,039$36.1M | +1,444,039 |
| BAKER BROS. ADVISORS LPnew · filed 14 Aug 2026 | 1,286,411$32.2M | +1,286,411 |
| Balyasny Asset Management L.P.added · filed 14 Aug 2026 | 1,042,198$26.1M | +1,025,993+6331.3% |
| Cormorant Asset Management, LPadded · filed 14 Aug 2026 | 1,028,242$7.7M | +722,020+235.8% |
| RA CAPITAL MANAGEMENT, L.P.new · filed 14 Aug 2026 | 722,020$18.1M | +722,020 |
| Vivo Capital, LLCunchanged · filed 14 Aug 2026 | 722,020$18.1M | 00.0% |
| Logos Global Management LPadded · filed 14 Aug 2026 | 722,020$18.1M | +692,020+2306.7% |
| Fairmount Funds Management LLCnew · filed 14 Aug 2026 | 722,020$18.1M | +722,020 |
| Caligan Partners LPadded · filed 14 Aug 2026 | 629,467$15.7M | +503,465+399.6% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.